ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
190,500
+500 (0.26%)
Mar 20, 2026, 3:30 PM KST

ABL Bio Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-37,806-55,529-2,6473,209-43,558
Depreciation & Amortization
3,4492,4102,5902,3252,158
Loss (Gain) From Sale of Assets
8.527.032.64-485.83
Loss (Gain) From Sale of Investments
-384.69-391.27-1,132592.13-6,666
Stock-Based Compensation
5,4372,8896,0014,3827,521
Provision & Write-off of Bad Debts
-----682.58
Other Operating Activities
-85.452,004-203.881,352-15.18
Change in Accounts Receivable
-59,112----
Change in Unearned Revenue
53,339-25,976-31,85963,562-3,160
Change in Other Net Operating Assets
-6,0995,184-1,113-3,2423,792
Operating Cash Flow
-41,253-69,403-28,36272,132-40,605
Capital Expenditures
-20,065-9,023-5,740-2,055-1,244
Sale of Property, Plant & Equipment
35.6512.787.4674.5112
Cash Acquisitions
----21,256-
Sale (Purchase) of Intangibles
-605.69-34.75-104.41-330.07-21.4
Sale (Purchase) of Real Estate
----1,252-
Investment in Securities
81,796-38,15235,941-46,23421,458
Other Investing Activities
752.7722.43-20.49-196.4617.62
Investing Cash Flow
62,113-47,17429,884-71,25020,221
Long-Term Debt Issued
12,000-44,831--
Long-Term Debt Repaid
-675.94-1,278-43,130-1,091-959.45
Net Debt Issued (Repaid)
11,324-1,2781,701-1,091-959.45
Issuance of Common Stock
21,221145,8571,7175,7531,256
Other Financing Activities
-26.18-7.39-1,981-11.67-12.36
Financing Cash Flow
32,519144,5721,4374,649284.13
Foreign Exchange Rate Adjustments
2,314229.74-29.86-1,9841,030
Net Cash Flow
55,69328,2252,9293,547-19,070
Free Cash Flow
-61,318-78,426-34,10270,076-41,850
Free Cash Flow Margin
-77.28%-234.79%-52.03%104.12%-784.87%
Free Cash Flow Per Share
-1190.47-1632.66-712.771473.23-890.99
Cash Interest Paid
1,132165.072,5211,205-
Cash Income Tax Paid
112.89-1,3461,621-2.6-75.7
Levered Free Cash Flow
-52,541-62,856-37,71063,171-
Unlevered Free Cash Flow
-51,920-62,833-36,36564,000-
Change in Working Capital
-11,871-20,792-32,97260,320631.38
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.